Patent · US Active

Prostate neoantigens and their uses

US11793843B2 · kind B2 · utility

0Cited by
121References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 9, 2020
Grant dateOct 24, 2023
Priority date
Expiry dateAug 26, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/10343
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure relates to prostate neoantigens, polynucleotides encoding them, vectors, host cells, recombinant virus particles, vaccines comprising the neoantigens, proteinaceous molecules binding the prostate neoantigens, and methods of making and using them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.